1 - 25 of 81 results for author:"Yamamoto R." in Literature citations
Results Customize
› Repeat search in UniProtKB (17,488)
| Novel APP/Abeta mutation K16N produces highly toxic heteromeric Abeta oligomers. Kaden D., Harmeier A., Weise C., Munter L.M., Althoff V., Rost B.R., Hildebrand P.W., Schmitz D., Schaefer M., Lurz R. et al. EMBO Mol Med 4:647-659(2012) · Mapped (10) |
| Effect of curcumin in a mouse model of Pelizaeus-Merzbacher disease. Yu L.H., Morimura T., Numata Y., Yamamoto R., Inoue N., Antalfy B., Goto Y., Deguchi K., Osaka H., Inoue K. Mol. Genet. Metab. 106:108-114(2012) · Mapped (3) |
| Distinct B-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells. Ghosn E.E., Yamamoto R., Hamanaka S., Yang Y., Herzenberg L.A., Nakauchi H., Herzenberg L.A. Proc. Natl. Acad. Sci. U.S.A. 109:5394-5398(2012) · Mapped (3) |
| Misexpression screen delineates novel genes controlling Drosophila lifespan. Paik D., Jang Y.G., Lee Y.E., Lee Y.N., Yamamoto R., Gee H.Y., Yoo S., Bae E., Min K.J., Tatar M. et al. Mech. Ageing Dev. 133:234-245(2012) · Mapped (145) |
| Agonist-independent constitutive activity of angiotensin II receptor promotes cardiac remodeling in mice. Yasuda N., Akazawa H., Ito K., Shimizu I., Kudo-Sakamoto Y., Yabumoto C., Yano M., Yamamoto R., Ozasa Y., Minamino T. et al. Hypertension 59:627-633(2012) · Mapped (1) |
| Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy. Shinzawa M., Yamamoto R., Nagasawa Y., Shoji T., Obi Y., Namba T., Kitamura H., Kaneko T., Okada N., Iwatani H. et al. Clin. Exp. Nephrol. 16:250-258(2012) · Mapped (2) |
| Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment. Ishihara M., Nishida C., Tashiro Y., Gritli I., Rosenkvist J., Koizumi M., Okaji Y., Yamamoto R., Yagita H., Okumura K. et al. Leukemia 26:332-339(2012) · Mapped (8) |
| Elevated serum IgE prior to acute severe infusion reaction during infliximab maintenance therapy in a Crohn's disease patient. Kato S., Kobayashi T., Kani K., Takabayashi H., Yamamoto R., Yakabi K. Inflamm. Bowel Dis. 17:E156-7(2011) · Mapped (1) |
| Inflammatory effect of advanced glycation end products on human meniscal cells from osteoarthritic knees. Hiraiwa H., Sakai T., Mitsuyama H., Hamada T., Yamamoto R., Omachi T., Ohno Y., Nakashima M., Ishiguro N. Inflamm. Res. 60:1039-1048(2011) · Mapped (5) |
| The defective protein level of myosin light chain phosphatase (MLCP) in the isolated saphenous vein, as a vascular conduit in coronary artery bypass grafting (CABG), harvested from patients with diabetes mellitus (DM). Matsuo Y., Kuwabara M., Tanaka-Totoribe N., Kanai T., Nakamura E., Gamoh S., Suzuki A., Asada Y., Hisa H., Yamamoto R. Biochem. Biophys. Res. Commun. 412:323-327(2011) · Mapped (3) |
| Suppression of a neocortical potassium channel activity by intracellular amyloid-beta and its rescue with Homer1a. Yamamoto K., Ueta Y., Wang L., Yamamoto R., Inoue N., Inokuchi K., Aiba A., Yonekura H., Kato N. J. Neurosci. 31:11100-11109(2011) · Mapped (6) |
| A candidate gene approach to genetic contributors to the development of IgA nephropathy. Yamamoto R., Nagasawa Y., Shoji T., Katakami N., Ohtoshi K., Hayaishi-Okano R., Yamasaki Y., Yamauchi A., Tsubakihara Y., Imai E. et al. Nephrol. Dial. Transplant. 27:1020-1030(2012) · Mapped (10) |
| Crystallization and preliminary X-ray crystallographic analysis of eIF5BDeltaN and the eIF5BDeltaN-eIF1ADeltaN complex. Zheng A., Yamamoto R., Sokabe M., Tanaka I., Yao M. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 67:730-733(2011) · Mapped (2) |
| Angiotensin II type 1 receptor signaling regulates feeding behavior through anorexigenic corticotropin-releasing hormone in hypothalamus. Yamamoto R., Akazawa H., Fujihara H., Ozasa Y., Yasuda N., Ito K., Kudo Y., Qin Y., Ueta Y., Komuro I. J. Biol. Chem. 286:21458-21465(2011) · Mapped (8) |
| Insulin receptor substrate chico acts with the transcription factor FOXO to extend Drosophila lifespan. Yamamoto R., Tatar M. Aging Cell 10:729-732(2011) · Mapped (3) |
| Urinary type IV collagen in nondiabetic kidney disease. Furumatsu Y., Nagasawa Y., Shoji T., Yamamoto R., Iio K., Matsui I., Takabatake Y., Kaimori J.Y., Iwatani H., Kaneko T. et al. Nephron Clin Pract 117:c160-6(2011) · Mapped (3) |
| Discrete PIH proteins function in the cytoplasmic preassembly of different subsets of axonemal dyneins. Yamamoto R., Hirono M., Kamiya R. J. Cell Biol. 190:65-71(2010) · UniProtKB (1) |
| Microarray analysis of tonsils in immunoglobulin A nephropathy patients. Iio K., Nagasawa Y., Iwatani H., Yamamoto R., Horii A., Okuzaki D., Furumatsu Y., Inohara H., Nojima H., Imai E. et al. Biochem. Biophys. Res. Commun. 393:565-570(2010) · Mapped (2) |
| Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type. Sakai T., Nishikori M., Tashima M., Yamamoto R., Kitawaki T., Takaori-Kondo A., Suzuki T., Tsuzuki S., Uchiyama T. Cancer Sci. 100:2361-2367(2009) · Mapped (3) |
| B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma. Yamamoto R., Nishikori M., Tashima M., Sakai T., Ichinohe T., Takaori-Kondo A., Ohmori K., Uchiyama T. Cancer Sci. 100:2093-2100(2009) · Mapped (3) |
| Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease. Higashi S., Moore D.J., Yamamoto R., Minegishi M., Sato K., Togo T., Katsuse O., Uchikado H., Furukawa Y., Hino H. et al. J. Neuropathol. Exp. Neurol. 68:994-1005(2009) · Mapped (4) |
| Overexpression of Ycg1 or Ydr520c confers resistance to cadmium in Saccharomyces cerevisiae. Hwang G.W., Sasaki K., Takahashi T., Yamamoto R., Naganuma A. J Toxicol Sci 34:441-443(2009) · Mapped (3) |
| PDK1 coordinates survival pathways and beta-adrenergic response in the heart. Ito K., Akazawa H., Tamagawa M., Furukawa K., Ogawa W., Yasuda N., Kudo Y., Liao C.H., Yamamoto R., Sato T. et al. Proc. Natl. Acad. Sci. U.S.A. 106:8689-8694(2009) · UniProtKB (1) · Mapped (12) |
| A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN). Yamamoto R., Nagasawa Y., Shoji T., Inoue K., Uehata T., Kaneko T., Okada T., Yamauchi A., Tsubakihara Y., Imai E. et al. Nephrol. Dial. Transplant. 24:3686-3694(2009) · Mapped (499) |
| The NatA acetyltransferase couples Sup35 prion complexes to the [PSI+] phenotype. Pezza J.A., Langseth S.X., Raupp Yamamoto R., Doris S.M., Ulin S.P., Salomon A.R., Serio T.R. Mol. Biol. Cell 20:1068-1080(2009) · Mapped (8) |